Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma

IMPORTANCE: Although the number of treatments for elderly patients with non–transplant-eligible (NTE) multiple myeloma (MM) has increased substantially, evidence is lacking on the clinical effectiveness and cost-effectiveness of novel treatment sequences. OBJECTIVE: To determine the optimal sequence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Autores principales: Blommestein, Hedwig M., Franken, Margreet G., van Beurden-Tan, Chrissy H. Y., Blijlevens, Nicole M. A., Huijgens, Peter C., Sonneveld, Pieter, Uyl-de Groot, Carin A., Zweegman, Sonja
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008287/
https://ncbi.nlm.nih.gov/pubmed/33779744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.3497
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares